Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Yamamoto

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Chemical & Pharmaceutical Bulletin|October 4, 2013
Synthesis and biological evaluation of thiophene-C-glucosides as sodium-dependent glucose cotransporter 2 inhibitorsShigeki Sakamaki, Eiji Kawanishi, Yuichi Koga, et al.
Scientific Reports|April 28, 2018
Transient elevation of cytoplasmic calcium ion concentration at a single cell level precedes morphological changes of epidermal keratinocytes during cornificationTeruasa Murata, Tetsuya Honda, Gyohei Egawa, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2022
Discovery of novel N-(1-benzyl-1H-imidazol-2-yl)amide derivatives as melanocortin 1 receptor agonistsAtsushi Sato, Ritsuo Imashiro, Hidekazu Tsujishima, et al.
Urology|July 13, 2004
Effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in patients with prostate cancerYoshiyuki Miyaji, Takashi Saika, Yasuo Yamamoto, et al.
Bioorganic & Medicinal Chemistry|August 8, 2007
CP5484, a novel quaternary carbapenem with potent anti-MRSA activity and reduced toxicityTakahisa Maruyama, Yasuo Yamamoto, Yuko Kano, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2013
N-Glucosides as human sodium-dependent glucose cotransporter 2 (hSGLT2) inhibitorsYasuo Yamamoto, Eiji Kawanishi, Yuichi Koga, et al.
European Journal of Pharmacology|January 21, 2021
JTP-117968, a novel selective glucocorticoid receptor modulator, exhibits significant anti-inflammatory effect while maintaining bone mineral density in miceTakafumi Kurimoto, Isao Tamai, Takashi Nakagawa, et al.
Journal of Medicinal Chemistry|December 6, 2024
Discovery of MT-7117 (Dersimelagon Phosphoric Acid): A Novel, Potent, Selective, and Nonpeptidic Orally Available Melanocortin 1 Receptor AgonistAtsushi Sato, Kenji Morokuma, Takashi Adachi, et al.
Journal of Medicinal Chemistry|August 10, 2010
Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitusSumihiro Nomura, Shigeki Sakamaki, Mitsuya Hongu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel Indole-N-glucoside, TA-1887 As a Sodium Glucose Cotransporter 2 Inhibitor for Treatment of Type 2 DiabetesSumihiro Nomura, Yasuo Yamamoto, Yosuke Matsumura, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Chemical & Pharmaceutical Bulletin|October 4, 2013
Synthesis and biological evaluation of thiophene-C-glucosides as sodium-dependent glucose cotransporter 2 inhibitorsShigeki Sakamaki, Eiji Kawanishi, Yuichi Koga, et al.
Scientific Reports|April 28, 2018
Transient elevation of cytoplasmic calcium ion concentration at a single cell level precedes morphological changes of epidermal keratinocytes during cornificationTeruasa Murata, Tetsuya Honda, Gyohei Egawa, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2022
Discovery of novel N-(1-benzyl-1H-imidazol-2-yl)amide derivatives as melanocortin 1 receptor agonistsAtsushi Sato, Ritsuo Imashiro, Hidekazu Tsujishima, et al.
Urology|July 13, 2004
Effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in patients with prostate cancerYoshiyuki Miyaji, Takashi Saika, Yasuo Yamamoto, et al.
Bioorganic & Medicinal Chemistry|August 8, 2007
CP5484, a novel quaternary carbapenem with potent anti-MRSA activity and reduced toxicityTakahisa Maruyama, Yasuo Yamamoto, Yuko Kano, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2013
N-Glucosides as human sodium-dependent glucose cotransporter 2 (hSGLT2) inhibitorsYasuo Yamamoto, Eiji Kawanishi, Yuichi Koga, et al.
European Journal of Pharmacology|January 21, 2021
JTP-117968, a novel selective glucocorticoid receptor modulator, exhibits significant anti-inflammatory effect while maintaining bone mineral density in miceTakafumi Kurimoto, Isao Tamai, Takashi Nakagawa, et al.
Journal of Medicinal Chemistry|December 6, 2024
Discovery of MT-7117 (Dersimelagon Phosphoric Acid): A Novel, Potent, Selective, and Nonpeptidic Orally Available Melanocortin 1 Receptor AgonistAtsushi Sato, Kenji Morokuma, Takashi Adachi, et al.
Journal of Medicinal Chemistry|August 10, 2010
Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitusSumihiro Nomura, Shigeki Sakamaki, Mitsuya Hongu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel Indole-N-glucoside, TA-1887 As a Sodium Glucose Cotransporter 2 Inhibitor for Treatment of Type 2 DiabetesSumihiro Nomura, Yasuo Yamamoto, Yosuke Matsumura, et al.
Pageof 4